Home LiteratureArticle Details
PMID: 15105135 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans.

Antimicrobial agents and chemotherapy ·Vol. 48 ·No. 5 ·2004-05-00 ·Pages 1778-87

Mukhopadhyay K, Prasad T, Saini P, Pucadyil TJ, Chattopadhyay A, Prasad R

Abstract

In this study, we examined the importance of membrane ergosterol and sphingolipids in the drug susceptibilities of Candida albicans. We used three independent methods to test the drug susceptibilities of erg mutant cells, which were defective in ergosterol biosynthesis. While spot and filter disk assays revealed that erg2 and erg16 mutant cells of C. albicans became hypersensitive to almost all of the drugs tested (i.e., 4-nitroquinoline oxide, terbinafine, o-phenanthroline, itraconazole, and ketoconazole), determination of the MIC at which 80% of the cells were inhibited revealed more than fourfold increase in susceptibility to ketoconazole and terbinafine. Treatment of wild-type C. albicans cells with fumonisin B1 resulted in 45% inhibition of sphingolipid biosynthesis and caused cells to become hypersensitive to the above drugs. Although erg mutants displayed enhanced membrane fluidity and passive diffusion, these changes alone were not sufficient to elicit the observed hypersusceptibility phenotype of erg mutants. For example, the induction in vitro of a 12% change in the membrane fluidity of C. albicans cells by a membrane fluidizer, benzyl alcohol, did not affect the drug susceptibilities of Candida cells. Additionally, the surface localization of green fluorescent protein-tagged Cdr1p, a major drug efflux pump protein of C. albicans, revealed that any disruption in ergosterol and sphingolipid interactions also interfered with its proper surface localization and functioning. A 50% reduction in the efflux of the Cdr1p substrate, rhodamine 6G, in erg mutant cells or in cells with a reduced sphingolipid content suggested a strong correlation between these membrane lipid components and this major efflux pump protein. Taken together, the results of our study demonstrate for the first time that there is an interaction between membrane ergosterol and sphingolipids, that a reduction in the content of either of these two components results in a disruption of this interaction, and that this disruption has deleterious effects on the drug susceptibilities of C. albicans cells.

MeSH Terms
Antifungal Agents/metabolism,pharmacology Candida albicans/drug effects,genetics,physiology Culture Media Drug Resistance, Multiple, Fungal Ergosterol/metabolism Fluorescence Polarization Immunoassay Fungal Proteins/genetics,metabolism Green Fluorescent Proteins Luminescent Proteins Membrane Lipids/metabolism Membrane Transport Proteins/genetics,metabolism Microbial Sensitivity Tests Microscopy, Confocal Microscopy, Fluorescence Spheroplasts/chemistry Sphingolipids/biosynthesis,physiology
Chemicals
Antifungal Agents CDR1 protein, Candida albicans Culture Media Fungal Proteins Luminescent Proteins Membrane Lipids Membrane Transport Proteins Sphingolipids Green Fluorescent Proteins Ergosterol
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Mukhopadhyay Kasturi
Membrane Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067. Centre for Cellular and Molecular Biology, Hyderabad 500007, India.
Prasad Tulika
Saini Preeti
Pucadyil Thomas J
Chattopadhyay Amitabha
Prasad Rajendra
References (45)
45 references, click to expand
  1. Sphingolipids with inositolphosphate-containing head groups.
    Adv Lipid Res. 1993;26:253-74 PMID: 8379454
  2. Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains.
    J Antimicrob Chemother. 1999 Jul;44(1):27-31 PMID: 10459807
  3. Physiological implications of sterol biosynthesis in yeast.
    Annu Rev Microbiol. 1995;49:95-116 PMID: 8561481
  4. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance.
    Antimicrob Agents Chemother. 1996 Dec;40(12):2835-41 PMID: 9124851
  5. Functional rafts in cell membranes.
    Nature. 1997 Jun 5;387(6633):569-72 PMID: 9177342
  6. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
    Antimicrob Agents Chemother. 1997 Jul;41(7):1482-7 PMID: 9210670
  7. Plasma membrane translocation of fluorescent-labeled phosphatidylethanolamine is controlled by transcription regulators, PDR1 and PDR3.
    J Cell Biol. 1997 Jul 28;138(2):255-70 PMID: 9230069
  8. Khafrefungin, a novel inhibitor of sphingolipid synthesis.
    J Biol Chem. 1997 Dec 19;272(51):32709-14 PMID: 9405490
  9. Major facilitator superfamily.
    Microbiol Mol Biol Rev. 1998 Mar;62(1):1-34 PMID: 9529885
  10. Molecular aspects of fluconazole resistance development in Candida albicans.
    Mycoses. 1999;42(7-8):453-8 PMID: 10546486
  11. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane.
    Eur J Biochem. 2000 Jan;267(2):277-94 PMID: 10632698
  12. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries.
    FEBS Lett. 2000 Jan 28;466(2-3):219-24 PMID: 10682831
  13. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains.
    FEMS Microbiol Lett. 2000 Apr 1;185(1):59-63 PMID: 10731607
  14. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast.
    Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3254-9 PMID: 10716729
  15. Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains.
    Biochemistry. 2000 Jul 4;39(26):7651-61 PMID: 10869171
  16. Multidrug resistance: a role for cholesterol efflux pathways?
    Trends Biochem Sci. 2000 Nov;25(11):530-4 PMID: 11084360
  17. Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences.
    Glycoconj J. 2000 Mar-Apr;17(3 -4):253-9 PMID: 11201798
  18. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    J Clin Microbiol. 2001 Mar;39(3):954-8 PMID: 11230410
  19. Lipid rafts and signal transduction.
    Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9 PMID: 11413487
  20. The involvement of sphingolipids in multidrug resistance.
    J Membr Biol. 2001 Jun 1;181(3):153-62 PMID: 11420602
  21. Coordinate control of sphingolipid biosynthesis and multidrug resistance in Saccharomyces cerevisiae.
    J Biol Chem. 2001 Jun 29;276(26):23674-80 PMID: 11323424
  22. Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide.
    J Biol Chem. 2001 Sep 7;276(36):33540-6 PMID: 11432870
  23. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Antimicrob Agents Chemother. 2001 Dec;45(12):3366-74 PMID: 11709310
  24. Plasma membrane proton ATPase Pma1p requires raft association for surface delivery in yeast.
    Mol Biol Cell. 2001 Dec;12(12):4129-38 PMID: 11739806
  25. Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism.
    J Biol Chem. 2002 Feb 8;277(6):3878-85 PMID: 11707431
  26. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators.
    Yeast. 2002 Mar 15;19(4):303-18 PMID: 11870854
  27. In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry.
    Antimicrob Agents Chemother. 2002 Apr;46(4):1046-52 PMID: 11897588
  28. Resistance mechanisms in clinical isolates of Candida albicans.
    Antimicrob Agents Chemother. 2002 Jun;46(6):1704-13 PMID: 12019079
  29. The genetic basis of fluconazole resistance development in Candida albicans.
    Biochim Biophys Acta. 2002 Jul 18;1587(2-3):240-8 PMID: 12084466
  30. Sterol-dependent regulation of sphingolipid metabolism in Saccharomyces cerevisiae.
    J Biol Chem. 2002 Jul 19;277(29):26177-84 PMID: 12006573
  31. Plasma membrane microdomains.
    Curr Opin Cell Biol. 2002 Aug;14(4):483-7 PMID: 12383800
  32. Drug susceptibilities of yeast cells are affected by membrane lipid composition.
    Antimicrob Agents Chemother. 2002 Dec;46(12):3695-705 PMID: 12435664
  33. Sterol-rich plasma membrane domains in the fission yeast Schizosaccharomyces pombe.
    J Cell Sci. 2003 Mar 1;116(Pt 5):867-74 PMID: 12571284
  34. Functional characterization of Candida albicans ABC transporter Cdr1p.
    Eukaryot Cell. 2003 Dec;2(6):1361-75 PMID: 14665469
  35. Filipin as a fluorescent probe for the location of cholesterol in the membranes of fragmented sarcoplasmic reticulum.
    Biochim Biophys Acta. 1973 Jan 2;291(1):61-70 PMID: 4265275
  36. Lateral diffusion in biological membranes. A normal-mode analysis of diffusion on a spherical surface.
    Biophys J. 1980 Apr;30(1):187-92 PMID: 7260266
  37. beta-Hydroxysterol distribution as determined by freeze-fracture cytochemistry.
    Histochem J. 1981 Jul;13(4):535-46 PMID: 6796549
  38. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles.
    J Biol Chem. 1992 Dec 15;267(35):24995-5002 PMID: 1360981
  39. Cholesterol regulates oxysterol binding protein (OSBP) phosphorylation and Golgi localization in Chinese hamster ovary cells: correlation with stimulation of sphingomyelin synthesis by 25-hydroxycholesterol.
    Biochem J. 1998 Nov 15;336 ( Pt 1):247-56 PMID: 9806908
  40. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells.
    J Biol Chem. 1998 Dec 4;273(49):32380-3 PMID: 9829965
  41. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.
    Antimicrob Agents Chemother. 1998 Dec;42(12):3065-72 PMID: 9835492
  42. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.
    Eur J Biochem. 1999 Jan;259(1-2):18-24 PMID: 9914470
  43. Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter of Candida albicans.
    FEMS Microbiol Lett. 1999 Apr 15;173(2):475-81 PMID: 10227177
  44. Metabolism and selected functions of sphingolipids in the yeast Saccharomyces cerevisiae.
    Biochim Biophys Acta. 1999 Jun 10;1438(3):305-21 PMID: 10366774
  45. Resistance of Candida albicans to azole antifungal agents.
    Biochem Soc Trans. 1993 Nov;21(4):1039-47 PMID: 8131894
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
2004-05-00
Pages
1778-87
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC400589
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]